| Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the US Preventive Services Task Force HJ De Koning, R Meza, SK Plevritis, K Ten Haaf, VN Munshi, J Jeon, ... Annals of internal medicine 160 (5), 311-320, 2014 | 519 | 2014 |
| Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience D Tan, SJ Horning, RT Hoppe, R Levy, SA Rosenberg, BM Sigal, ... Blood, The Journal of the American Society of Hematology 122 (6), 981-987, 2013 | 288 | 2013 |
| Risk prediction models for selection of lung cancer screening candidates: a retrospective validation study K Ten Haaf, J Jeon, MC Tammemägi, SS Han, CY Kong, SK Plevritis, ... PLoS medicine 14 (4), e1002277, 2017 | 273 | 2017 |
| Evaluation of the benefits and harms of lung cancer screening with low-dose computed tomography: modeling study for the US Preventive Services Task Force R Meza, J Jeon, I Toumazis, K Ten Haaf, P Cao, M Bastani, SS Han, ... Jama 325 (10), 988-997, 2021 | 245 | 2021 |
| Genes controlling affiliative behavior as candidate genes for autism CM Yrigollen, SS Han, A Kochetkova, T Babitz, JT Chang, FR Volkmar, ... Biological psychiatry 63 (10), 911-916, 2008 | 224 | 2008 |
| Von Hippel-Lindau (VHL) Inactivation in Sporadic Clear Cell Renal Cancer: Associations with Germline VHL Polymorphisms and Etiologic Risk Factors LE Moore, ML Nickerson, P Brennan, JR Toro, E Jaeger, J Rinsky, ... PLoS genetics 7 (10), e1002312, 2011 | 217 | 2011 |
| Risk-Based lung cancer screening: A systematic review I Toumazis, M Bastani, SS Han, SK Plevritis Lung cancer 147, 154-186, 2020 | 179 | 2020 |
| Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer M Garcia-Closas, N Rothman, JD Figueroa, L Prokunina-Olsson, SS Han, ... Cancer research 73 (7), 2211-2220, 2013 | 150 | 2013 |
| Macrophage migration inhibitory factor and autism spectrum disorders EL Grigorenko, SS Han, CM Yrigollen, L Leng, Y Mizue, GM Anderson, ... Pediatrics 122 (2), e438-e445, 2008 | 143 | 2008 |
| Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes JV Aredo, SK Padda, CA Kunder, SS Han, JW Neal, JB Shrager, ... Lung Cancer 133, 144-150, 2019 | 114 | 2019 |
| Durvalumab for stage III EGFR-mutated NSCLC after definitive chemoradiotherapy JV Aredo, I Mambetsariev, JA Hellyer, A Amini, JW Neal, SK Padda, ... Journal of Thoracic Oncology 16 (6), 1030-1041, 2021 | 96 | 2021 |
| A comparative modeling analysis of risk-based lung cancer screening strategies K Ten Haaf, M Bastani, P Cao, J Jeon, I Toumazis, SS Han, SK Plevritis, ... JNCI: Journal of the National Cancer Institute 112 (5), 466-479, 2020 | 93 | 2020 |
| Association of Klotho-VS heterozygosity with risk of Alzheimer disease in individuals who carry APOE4 ME Belloy, V Napolioni, SS Han, Y Le Guen, MD Greicius, ... JAMA neurology 77 (7), 849-862, 2020 | 91 | 2020 |
| Development and validation of a multivariable lung cancer risk prediction model that includes low-dose computed tomography screening results: a secondary analysis of data from … MC Tammemägi, K Ten Haaf, I Toumazis, CY Kong, SS Han, J Jeon, ... JAMA network open 2 (3), e190204-e190204, 2019 | 90 | 2019 |
| Variants in or near KITLG, BAK1, DMRT1, and TERT-CLPTM1L predispose to familial testicular germ cell tumour CP Kratz, SS Han, PS Rosenberg, SI Berndt, L Burdett, M Yeager, ... Journal of medical genetics 48 (7), 473-476, 2011 | 90 | 2011 |
| Risk stratification for second primary lung cancer SS Han, GA Rivera, MC Tammemägi, SK Plevritis, SL Gomez, I Cheng, ... Journal of Clinical Oncology 35 (25), 2893, 2017 | 86 | 2017 |
| Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials R Meza, K ten Haaf, CY Kong, A Erdogan, WC Black, MC Tammemagi, ... Cancer 120 (11), 1713-1724, 2014 | 84 | 2014 |
| Comparison of treatments for cocaine use disorder among adults: a systematic review and meta-analysis BS Bentzley, SS Han, S Neuner, K Humphreys, KM Kampman, ... JAMA network open 4 (5), e218049-e218049, 2021 | 83 | 2021 |
| Higher absolute lymphocyte counts predict lower mortality from early-stage triple-negative breast cancer A Afghahi, N Purington, SS Han, M Desai, E Pierson, MB Mathur, T Seto, ... Clinical Cancer Research 24 (12), 2851-2858, 2018 | 75 | 2018 |
| Association of COVID-19 vaccination with SARS-CoV-2 infection in patients with cancer: a US nationwide veterans affairs study JTY Wu, J La, W Branch-Elliman, LB Huhmann, SS Han, G Parmigiani, ... JAMA oncology 8 (2), 281-286, 2022 | 71 | 2022 |
Rafael MezaBC Cancer Research InstituteVerified email at bccrc.ca
